Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone

No Thumbnail Available

Authors

Krasner, Carolyn N.
Poveda, Andres
Herzog, Thomas J.
Vermorken, Jan B.
Kaye, Stanley B.
Nieto, Antonio
Claret, Pilar L.
Park, Youn C.
Parekh, Trilok
Monk, Bradley J.

Issue Date

2012

Volume

127

Issue

1

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Krasner, Carolyn N.; Poveda, Andres; Herzog, Thomas J.; Vermorken, Jan B.; Kaye, Stanley B.; Nieto, Antonio; Claret, Pilar Lardelli; Park, Youn Choi; Parekh, Trilok; Monk, Bradley J. Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone. Gynecologic oncology. 2012, 127(1):161-167.

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

Identifier

ISSN

0090-8258
1095-6859

EISSN

Collections